MAPT and Alzheimer disease: Alzheimer’s disease (AD) is an aging-related neurodegenerative disease characterized by profound cognitive impairments and distinct brain pathology including amyloid β (Aβ) deposition and tau hyper-phosphorylation (Holtzman et al., 2012; Association, 2019; Ma, 2021).